China Non-opioid Pain Patch Market Report & Forecast 2021-2027

Publisher Name :
Date: 26-Oct-2021
No. of pages: 107
Inquire Before Buying

China Non-opioid Pain Patch Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)

China Non-opioid Pain Patch Market Segment Percentages, By Type, 2020 (%)

- Lidocaine Patches

- Diclofenac Patches

- Indomethacin Patches

- Counter-Irritant Patches

- Fentanyl Patches

- Others

China Non-opioid Pain Patch Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)

China Non-opioid Pain Patch Market Segment Percentages, By Application, 2020 (%)

- OTC

- Rx

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-opioid Pain Patch revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Non-opioid Pain Patch revenues share in China market, 2020 (%)

Key companies Non-opioid Pain Patch sales in China market, 2016-2021 (Estimated), (M Units)

Key companies Non-opioid Pain Patch sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Hisamitsu

- Mylan

- Johnson & Johnson

- Actavis

- Lingrui

- Teikoku Seiyaku

- Sanofi

- Novartis

- Qizheng

- Endo

- Huarun 999

- GSK

- Haw Par

- Nichiban

- Mentholatum

- Laboratoires Genevrier

- BLUE-EMU

China Non-opioid Pain Patch Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Non-opioid Pain Patch Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Non-opioid Pain Patch Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Non-opioid Pain Patch Overall Market Size
2.1 China Non-opioid Pain Patch Market Size: 2021 VS 2027
2.2 China Non-opioid Pain Patch Revenue, Prospects & Forecasts: 2016-2027
2.3 China Non-opioid Pain Patch Sales: 2016-2027
3 Company Landscape
3.1 Top Non-opioid Pain Patch Players in China Market
3.2 Top China Non-opioid Pain Patch Companies Ranked by Revenue
3.3 China Non-opioid Pain Patch Revenue by Companies
3.4 China Non-opioid Pain Patch Sales by Companies
3.5 China Non-opioid Pain Patch Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Non-opioid Pain Patch Companies in China Market, by Revenue in 2020
3.7 Manufacturers Non-opioid Pain Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-opioid Pain Patch Players in China Market
3.8.1 List of Tier 1 Non-opioid Pain Patch Companies in China
3.8.2 List of Tier 2 and Tier 3 Non-opioid Pain Patch Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Non-opioid Pain Patch Market Size Markets, 2021 & 2027
4.1.2 Lidocaine Patches
4.1.3 Diclofenac Patches
4.1.4 Indomethacin Patches
4.1.5 Counter-Irritant Patches
4.1.6 Fentanyl Patches
4.1.7 Others
4.2 By Type - China Non-opioid Pain Patch Revenue & Forecasts
4.2.1 By Type - China Non-opioid Pain Patch Revenue, 2016-2021
4.2.2 By Type - China Non-opioid Pain Patch Revenue, 2022-2027
4.2.3 By Type - China Non-opioid Pain Patch Revenue Market Share, 2016-2027
4.3 By Type - China Non-opioid Pain Patch Sales & Forecasts
4.3.1 By Type - China Non-opioid Pain Patch Sales, 2016-2021
4.3.2 By Type - China Non-opioid Pain Patch Sales, 2022-2027
4.3.3 By Type - China Non-opioid Pain Patch Sales Market Share, 2016-2027
4.4 By Type - China Non-opioid Pain Patch Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Non-opioid Pain Patch Market Size, 2021 & 2027
5.1.2 OTC
5.1.3 Rx
5.2 By Application - China Non-opioid Pain Patch Revenue & Forecasts
5.2.1 By Application - China Non-opioid Pain Patch Revenue, 2016-2021
5.2.2 By Application - China Non-opioid Pain Patch Revenue, 2022-2027
5.2.3 By Application - China Non-opioid Pain Patch Revenue Market Share, 2016-2027
5.3 By Application - China Non-opioid Pain Patch Sales & Forecasts
5.3.1 By Application - China Non-opioid Pain Patch Sales, 2016-2021
5.3.2 By Application - China Non-opioid Pain Patch Sales, 2022-2027
5.3.3 By Application - China Non-opioid Pain Patch Sales Market Share, 2016-2027
5.4 By Application - China Non-opioid Pain Patch Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Hisamitsu
6.1.1 Hisamitsu Corporation Information
6.1.2 Hisamitsu Overview
6.1.3 Hisamitsu Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.1.4 Hisamitsu Non-opioid Pain Patch Product Description
6.1.5 Hisamitsu Recent Developments
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Overview
6.2.3 Mylan Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.2.4 Mylan Non-opioid Pain Patch Product Description
6.2.5 Mylan Recent Developments
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.3.4 Johnson & Johnson Non-opioid Pain Patch Product Description
6.3.5 Johnson & Johnson Recent Developments
6.4 Actavis
6.4.1 Actavis Corporation Information
6.4.2 Actavis Overview
6.4.3 Actavis Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.4.4 Actavis Non-opioid Pain Patch Product Description
6.4.5 Actavis Recent Developments
6.5 Lingrui
6.5.1 Lingrui Corporation Information
6.5.2 Lingrui Overview
6.5.3 Lingrui Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.5.4 Lingrui Non-opioid Pain Patch Product Description
6.5.5 Lingrui Recent Developments
6.6 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Corporation Information
6.6.2 Teikoku Seiyaku Overview
6.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Description
6.6.5 Teikoku Seiyaku Recent Developments
6.7 Sanofi
6.7.1 Sanofi Corporation Information
6.7.2 Sanofi Overview
6.7.3 Sanofi Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.7.4 Sanofi Non-opioid Pain Patch Product Description
6.7.5 Sanofi Recent Developments
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Overview
6.8.3 Novartis Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.8.4 Novartis Non-opioid Pain Patch Product Description
6.8.5 Novartis Recent Developments
6.9 Qizheng
6.9.1 Qizheng Corporation Information
6.9.2 Qizheng Overview
6.9.3 Qizheng Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.9.4 Qizheng Non-opioid Pain Patch Product Description
6.9.5 Qizheng Recent Developments
6.10 Endo
6.10.1 Endo Corporation Information
6.10.2 Endo Overview
6.10.3 Endo Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.10.4 Endo Non-opioid Pain Patch Product Description
6.10.5 Endo Recent Developments
6.11 Huarun 999
6.11.1 Huarun 999 Corporation Information
6.11.2 Huarun 999 Overview
6.11.3 Huarun 999 Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.11.4 Huarun 999 Non-opioid Pain Patch Product Description
6.11.5 Huarun 999 Recent Developments
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Overview
6.12.3 GSK Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.12.4 GSK Non-opioid Pain Patch Product Description
6.12.5 GSK Recent Developments
6.13 Haw Par
6.13.1 Haw Par Corporation Information
6.13.2 Haw Par Overview
6.13.3 Haw Par Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.13.4 Haw Par Non-opioid Pain Patch Product Description
6.13.5 Haw Par Recent Developments
6.14 Nichiban
6.14.1 Nichiban Corporation Information
6.14.2 Nichiban Overview
6.14.3 Nichiban Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.14.4 Nichiban Non-opioid Pain Patch Product Description
6.14.5 Nichiban Recent Developments
6.15 Mentholatum
6.15.1 Mentholatum Corporation Information
6.15.2 Mentholatum Overview
6.15.3 Mentholatum Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.15.4 Mentholatum Non-opioid Pain Patch Product Description
6.15.5 Mentholatum Recent Developments
6.16 Laboratoires Genevrier
6.16.1 Laboratoires Genevrier Corporation Information
6.16.2 Laboratoires Genevrier Overview
6.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Description
6.16.5 Laboratoires Genevrier Recent Developments
6.17 BLUE-EMU
6.17.1 BLUE-EMU Corporation Information
6.17.2 BLUE-EMU Overview
6.17.3 BLUE-EMU Non-opioid Pain Patch Sales and Revenue in China Market (2016-2021)
6.17.4 BLUE-EMU Non-opioid Pain Patch Product Description
6.17.5 BLUE-EMU Recent Developments
7 China Non-opioid Pain Patch Production Capacity, Analysis
7.1 China Non-opioid Pain Patch Production Capacity, 2016-2027
7.2 Non-opioid Pain Patch Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Non-opioid Pain Patch Supply Chain Analysis
9.1 Non-opioid Pain Patch Industry Value Chain
9.2 Non-opioid Pain Patch Upstream Market
9.3 Non-opioid Pain Patch Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Non-opioid Pain Patch Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Non-opioid Pain Patch in China Market
Table 2. Top Non-opioid Pain Patch Players in China Market, Ranking by Revenue (2019)
Table 3. China Non-opioid Pain Patch Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Non-opioid Pain Patch Revenue Share by Companies, 2016-2021
Table 5. China Non-opioid Pain Patch Sales by Companies, (M Units), 2016-2021
Table 6. China Non-opioid Pain Patch Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Non-opioid Pain Patch Price (2016-2021) & (USD/K Units)
Table 8. Manufacturers Non-opioid Pain Patch Product Type
Table 9. List of Tier 1 Non-opioid Pain Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Non-opioid Pain Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Lidocaine Patches
Table 12. Major Manufacturers of Diclofenac Patches
Table 13. By Type - China Non-opioid Pain Patch Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Non-opioid Pain Patch Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Non-opioid Pain Patch Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Non-opioid Pain Patch Sales (M Units), 2016-2021
Table 17. By Type - China Non-opioid Pain Patch Sales (M Units), 2022-2027
Table 18. By Application - China Non-opioid Pain Patch Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Non-opioid Pain Patch Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Non-opioid Pain Patch Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Non-opioid Pain Patch Sales (M Units), 2016-2021
Table 22. By Application - China Non-opioid Pain Patch Sales (M Units), 2022-2027
Table 23. Hisamitsu Corporation Information
Table 24. Hisamitsu Description and Major Businesses
Table 25. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 26. Hisamitsu Non-opioid Pain Patch Product
Table 27. Hisamitsu Recent Developments
Table 28. Mylan Corporation Information
Table 29. Mylan Description and Major Businesses
Table 30. Mylan Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 31. Mylan Non-opioid Pain Patch Product
Table 32. Mylan Recent Developments
Table 33. Johnson & Johnson Corporation Information
Table 34. Johnson & Johnson Description and Major Businesses
Table 35. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 36. Johnson & Johnson Non-opioid Pain Patch Product
Table 37. Johnson & Johnson Recent Developments
Table 38. Actavis Corporation Information
Table 39. Actavis Description and Major Businesses
Table 40. Actavis Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 41. Actavis Non-opioid Pain Patch Product
Table 42. Actavis Recent Developments
Table 43. Lingrui Corporation Information
Table 44. Lingrui Description and Major Businesses
Table 45. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 46. Lingrui Non-opioid Pain Patch Product
Table 47. Lingrui Recent Developments
Table 48. Teikoku Seiyaku Corporation Information
Table 49. Teikoku Seiyaku Description and Major Businesses
Table 50. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 51. Teikoku Seiyaku Non-opioid Pain Patch Product
Table 52. Teikoku Seiyaku Recent Developments
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Major Businesses
Table 55. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 56. Sanofi Non-opioid Pain Patch Product
Table 57. Sanofi Recent Developments
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Major Businesses
Table 60. Novartis Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 61. Novartis Non-opioid Pain Patch Product
Table 62. Novartis Recent Developments
Table 63. Qizheng Corporation Information
Table 64. Qizheng Description and Major Businesses
Table 65. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 66. Qizheng Non-opioid Pain Patch Product
Table 67. Qizheng Recent Developments
Table 68. Endo Corporation Information
Table 69. Endo Description and Major Businesses
Table 70. Endo Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 71. Endo Non-opioid Pain Patch Product
Table 72. Endo Recent Developments
Table 73. Huarun 999 Corporation Information
Table 74. Huarun 999 Description and Major Businesses
Table 75. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 76. Huarun 999 Non-opioid Pain Patch Product
Table 77. Huarun 999 Recent Developments
Table 78. GSK Corporation Information
Table 79. GSK Description and Major Businesses
Table 80. GSK Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 81. GSK Non-opioid Pain Patch Product
Table 82. GSK Recent Developments
Table 83. Haw Par Corporation Information
Table 84. Haw Par Description and Major Businesses
Table 85. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 86. Haw Par Non-opioid Pain Patch Product
Table 87. Haw Par Recent Developments
Table 88. Nichiban Corporation Information
Table 89. Nichiban Description and Major Businesses
Table 90. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 91. Nichiban Non-opioid Pain Patch Product
Table 92. Nichiban Recent Developments
Table 93. Mentholatum Corporation Information
Table 94. Mentholatum Description and Major Businesses
Table 95. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 96. Mentholatum Non-opioid Pain Patch Product
Table 97. Mentholatum Recent Developments
Table 98. Laboratoires Genevrier Corporation Information
Table 99. Laboratoires Genevrier Description and Major Businesses
Table 100. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 101. Laboratoires Genevrier Non-opioid Pain Patch Product
Table 102. Laboratoires Genevrier Recent Developments
Table 103. BLUE-EMU Corporation Information
Table 104. BLUE-EMU Description and Major Businesses
Table 105. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/K Units) (2016-2021)
Table 106. BLUE-EMU Non-opioid Pain Patch Product
Table 107. BLUE-EMU Recent Developments
Table 108. Non-opioid Pain Patch Production Capacity (M Units) of Key Manufacturers in China Market, 2019-2021 (M Units)
Table 109. China Non-opioid Pain Patch Capacity Market Share of Key Manufacturers, 2019-2021
Table 110. Non-opioid Pain Patch Market Opportunities & Trends in China Market
Table 111. Non-opioid Pain Patch Market Drivers in China Market
Table 112. Non-opioid Pain Patch Market Restraints in China Market
Table 113. Non-opioid Pain Patch Raw Materials
Table 114. Non-opioid Pain Patch Raw Materials Suppliers in China Market
Table 115. Typical Non-opioid Pain Patch Downstream
Table 116. Non-opioid Pain Patch Downstream Clients in China Market
Table 117. Non-opioid Pain Patch Distributors and Sales Agents in China Market
List of Figures
Figure 1. Non-opioid Pain Patch Product Picture
Figure 2. Non-opioid Pain Patch Segment by Type
Figure 3. Non-opioid Pain Patch Segment by Application
Figure 4. China Non-opioid Pain Patch Market Overview: 2020
Figure 5. China Non-opioid Pain Patch Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Non-opioid Pain Patch Revenue, 2016-2027 (US$, Mn)
Figure 7. Non-opioid Pain Patch Sales in China Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-opioid Pain Patch Revenue in 2020
Figure 9. Lidocaine Patches Product Picture
Figure 10. Diclofenac Patches Product Picture
Figure 11. Indomethacin Patches Product Picture
Figure 12. Counter-Irritant Patches Product Picture
Figure 13. Fentanyl Patches Product Picture
Figure 14. By Type - China Non-opioid Pain Patch Sales Market Share, 2016-2027
Figure 15. By Type - China Non-opioid Pain Patch Revenue Market Share, 2016-2027
Figure 16. By Type - China Non-opioid Pain Patch Price (USD/K Units), 2016-2027
Figure 17. OTC
Figure 18. Rx
Figure 19. By Application - China Non-opioid Pain Patch Sales Market Share, 2016-2027
Figure 20. By Application - China Non-opioid Pain Patch Revenue Market Share, 2016-2027
Figure 21. By Application - China Non-opioid Pain Patch Price (USD/K Units), 2016-2027
Figure 22. Hisamitsu Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Mylan Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Johnson & Johnson Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Actavis Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Lingrui Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Teikoku Seiyaku Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Sanofi Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Novartis Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Qizheng Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Endo Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Huarun 999 Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. GSK Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Haw Par Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Nichiban Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Mentholatum Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Laboratoires Genevrier Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BLUE-EMU Non-opioid Pain Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. China Non-opioid Pain Patch Production Capacity (M Units), 2016-2027
Figure 40. Non-opioid Pain Patch Industry Value Chain
Figure 41. Marketing Channels
  • 2021-2030 Report on Global Home Health Testing Services Market by Player, Region, Type, Application and Sales Channel
    Published: 30-Nov-2021        Price: US 2500 Onwards        Pages: 136
    This report studies the Home Health Testing Services market, covering market size for segment by type (Men's Health, Women's Health, etc.), by application (Individuals, Organizations & Enterprises, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Everlywell, Modern Fertility, Future Family, 23andMe, Cue Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analys......
  • 2021-2030 Report on Global Thioctic Acid (Alpha Lipoic Acid) Market by Player, Region, Type, Application and Sales Channel
    Published: 30-Nov-2021        Price: US 2500 Onwards        Pages: 102
    This report studies the Thioctic Acid (Alpha Lipoic Acid) market, covering market size for segment by type (Medical Grade, Food Grade, etc.), by application (Health Care, Pharmaceutical, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Tonghe, Shyndec, Fushilai Pharmaceutical, Maidesen, Taike Biological, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • Global Pet Insect Repellent Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 105
    According to this latest study, the 2021 growth of Pet Insect Repellent will have significant change from previous year. By the most conservative estimates of global Pet Insect Repellent market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pet Insect Repellent market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. This report present......
  • Global Calcium Supplements for Kids Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 119
    According to this latest study, the 2021 growth of Calcium Supplements for Kids will have significant change from previous year. By the most conservative estimates of global Calcium Supplements for Kids market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Calcium Supplements for Kids market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. ......
  • Global Pets Parasite Prevention and Control Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 90
    According to this latest study, the 2021 growth of Pets Parasite Prevention and Control will have significant change from previous year. By the most conservative estimates of global Pets Parasite Prevention and Control market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pets Parasite Prevention and Control market will register a % CAGR in terms of revenue, the global market size will reach US$ mil......
  • Global Animals Parasite Prevention and Control Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 93
    According to this latest study, the 2021 growth of Animals Parasite Prevention and Control will have significant change from previous year. By the most conservative estimates of global Animals Parasite Prevention and Control market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Animals Parasite Prevention and Control market will register a % CAGR in terms of revenue, the global market size will reach......
  • Global Antisense Oligonucleotide Therapies Market Growth (Status and Outlook) 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 81
    According to this latest study, the 2021 growth of Antisense Oligonucleotide Therapies will have significant change from previous year. By the most conservative estimates of global Antisense Oligonucleotide Therapies market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Antisense Oligonucleotide Therapies market will register a % CAGR in terms of revenue, the global market size will reach US$ millio......
  • Global Cattle Vaccine Market Growth (Status and Outlook) 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 87
    According to this latest study, the 2021 growth of Cattle Vaccine will have significant change from previous year. By the most conservative estimates of global Cattle Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ 1449.6 million in 2020. Over the next five years the Cattle Vaccine market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 1861.6 million by 2026. This report presents a ......
  • Global Pets Anti-infective Drugs Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 101
    According to this latest study, the 2021 growth of Pets Anti-infective Drugs will have significant change from previous year. By the most conservative estimates of global Pets Anti-infective Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pets Anti-infective Drugs market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. This......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs